Total Funding
35
64
Total FundingSeries A raised
Growth Score 35 in past quarter
-2 pts
Heat Score 64 in past quarter
-18 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
137248
InFuse Holdings operates high-quality, cost-effective ambulatory infusion centers.
David Rothenberg: Co-Founder & Board MemberPast Role: MDLinx, President / CEO
Eric Richman: Co-Founder & Board MemberPast Role: Horizon Infusions, Director & Co-Founder
About the Company
InFuse Holdings operates high-quality, cost-effective ambulatory infusion centers. The infrastructure in the US for infusion therapies is lacking and, in most communities today, infusions centers have a wide range of cost and quality. InFuse Holdings brings best practices – in the workflow, inventory management, scheduling, safety protocols,
staffing, customer experience, and outcomes data collection and reporting – to provide patients with a convenient, safe, and caring environment. The ambulatory infusion center model allows InFuse to provide these services at a lower cost than other delivery channels, helping to decrease the overall cost of healthcare for patients, employers, and payors.
